Browsing Tag
Northpond Ventures
2 posts
Chemomab Therapeutics (CMMB) and Scipher Medicine to merge in $150m reverse deal
Scipher Medicine and Chemomab are merging in all-stock deal, taking Scipher public via reverse merger. $30M PIPE led by Northpond. Q4 2026 close, H1 2028 Phase 2 data.
July 8, 2026
Australian clinical diagnostics company SpeeDx raises $15m in Series B round
SpeeDx, an Australian clinical diagnostics company, to support improved patient outcomes, has secured $15 million in a Series…
February 12, 2020